Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kronenberger

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Journal of Viral Hepatitis|January 12, 2012
New developments in HCV therapyB Kronenberger, S Zeuzem
Dysphagia|January 1, 1994
Dysphagia following head and neck cancer surgeryM B Kronenberger, A D Meyers
Deutsche Medizinische Wochenschrift (1946)|September 5, 2013
[interferon-free treatment of hepatitis C: how and when will it become reality? [corrected]]B Kronenberger, T M Welzel, S Zeuzem
Der Internist|March 13, 2015
[Treatment of hepatitis C]M D Schneider, B Kronenberger, S Zeuzem, et al.
Alimentary Pharmacology & Therapeutics|May 6, 2015
Letter: proton pump inhibitor treatment and increased mortality in cirrhotic patients--authors' replyG Dultz, A Piiper, S Zeuzem, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2015
Letter: proton pump inhibitors - severity of liver disease and mortality in patients with cirrhosis - authors' replyG Dultz, A Piiper, S Zeuzem, et al.
Alimentary Pharmacology & Therapeutics|December 20, 2014
Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosisG Dultz, A Piiper, S Zeuzem, et al.
Zeitschrift Fur Gastroenterologie|March 14, 2014
[Cytokeratin 18 as marker for non-invasive diagnosis and prognosis of acute and chronic liver diseases]A Canbay, A Feldstein, B Kronenberger, et al.
Emerging Infectious Diseases|April 1, 1996
Invasive penicillin-resistant pneumococcal infections: a prevalence and historical cohort studyC B Kronenberger, R E Hoffman, D C Lezotte, et al.
Molecular Pharmacology|August 23, 2000
Pertussis toxin inhibits cholecystokinin- and epidermal growth factor-induced mitogen-activated protein kinase activation by disinhibition of the cAMP signaling pathway and inhibition of c-Raf-1A Piiper, R Gebhardt, B Kronenberger, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Journal of Viral Hepatitis|January 12, 2012
New developments in HCV therapyB Kronenberger, S Zeuzem
Dysphagia|January 1, 1994
Dysphagia following head and neck cancer surgeryM B Kronenberger, A D Meyers
Deutsche Medizinische Wochenschrift (1946)|September 5, 2013
[interferon-free treatment of hepatitis C: how and when will it become reality? [corrected]]B Kronenberger, T M Welzel, S Zeuzem
Der Internist|March 13, 2015
[Treatment of hepatitis C]M D Schneider, B Kronenberger, S Zeuzem, et al.
Alimentary Pharmacology & Therapeutics|May 6, 2015
Letter: proton pump inhibitor treatment and increased mortality in cirrhotic patients--authors' replyG Dultz, A Piiper, S Zeuzem, et al.
Alimentary Pharmacology & Therapeutics|March 5, 2015
Letter: proton pump inhibitors - severity of liver disease and mortality in patients with cirrhosis - authors' replyG Dultz, A Piiper, S Zeuzem, et al.
Alimentary Pharmacology & Therapeutics|December 20, 2014
Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosisG Dultz, A Piiper, S Zeuzem, et al.
Zeitschrift Fur Gastroenterologie|March 14, 2014
[Cytokeratin 18 as marker for non-invasive diagnosis and prognosis of acute and chronic liver diseases]A Canbay, A Feldstein, B Kronenberger, et al.
Emerging Infectious Diseases|April 1, 1996
Invasive penicillin-resistant pneumococcal infections: a prevalence and historical cohort studyC B Kronenberger, R E Hoffman, D C Lezotte, et al.
Molecular Pharmacology|August 23, 2000
Pertussis toxin inhibits cholecystokinin- and epidermal growth factor-induced mitogen-activated protein kinase activation by disinhibition of the cAMP signaling pathway and inhibition of c-Raf-1A Piiper, R Gebhardt, B Kronenberger, et al.
Pageof 4